Maximilian Mossner

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.

Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.

Journal: Cancer research

Published: January 29, 2025

Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitis.

Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitis.

Journal: medRxiv : the preprint server for health sciences

Published: July 23, 2024

A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities.

A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities.

Journal: EMBO molecular medicine

Published: July 17, 2024

Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis.

Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis.

Journal: Gut

Published: July 12, 2024

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Journal: Cancer discovery

Published: June 11, 2024

Alleviating the burden of depression: a simulation study on the impact of mental health services.

Alleviating the burden of depression: a simulation study on the impact of mental health services.

Journal: Epidemiology and psychiatric sciences

Published: April 02, 2024

Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding.

Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding.

Journal: Nature communications

Published: March 06, 2024

Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer.

Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer.

Journal: bioRxiv : the preprint server for biology

Published: February 26, 2024

Epigenetically driven and early immune evasion in colorectal cancer evolution.

Epigenetically driven and early immune evasion in colorectal cancer evolution.

Journal: Nature genetics

Published: February 12, 2024

Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

Journal: Annals of hematology

Published: December 19, 2023

Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer.

Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 07, 2023

Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers.

Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers.

Journal: The Journal of molecular diagnostics : JMD

Published: June 23, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026